Clinical Trial

The Electronic Asthma Management System in Pharmacies

Study acronym: eAMS-Pharm
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated August 17, 2025 (before its estimated December 23, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to assess the effect of an electronic asthma management system in pharmacies (eAMS-Pharm) on asthma control assessment, asthma medication adjustment, asthma action plan delivery, and prompting for specialist referral in severe asthma. The study assesses the differences on pharmacy processes (affecting both the pharmacy team and patients) and pharmacy-delivered care using an interrupted time-series analysis (six-months before vs. six-months after the introduction of eAMS-Pharm in study pharmacy sites). The eAMS-Pharm uses patient data (asthma control, asthma flare-up risk, and current medications) to provide clinical decision support to pharmacists, empowering them to bridge existing gaps between guideline-recommended asthma care and patient care received.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-17.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-08-15
Trial Details
NCT Number NCT07038642
Lead Sponsor Unity Health Toronto
Conditions Pharmacy, Asthma Management, Asthma, Computerized Decision Support System
Enrollment 100 participants
Start Date 2025-06-23
Primary Completion 2025-12-23 (estimated)
Study Completion 2026-01-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-17